Valneva SE (VALN) Research & Development (2021 - 2026)

Valneva SE's (VALN) quarterly Research & Development came in at -$17.8 million in Q1 2026, down 13.25% year-on-year from -$20.5 million in Q1 2025, and down 110.55% quarter-over-quarter from $168.8 million in Q4 2025.

Valneva SE (VALN) Research & Development (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Research & Development across 6 years of filings, most recently posting -$17.8 million for Q1 2026.

  • Research & Development for Q1 2026 came in at -$17.8 million, down 13.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $99.3 million (up 29.26% YoY), and the FY2025 annual result was $99.3 million, up 25.33% from the prior year.
  • Research & Development came in at -$17.8 million for Q1 2026 at Valneva SE, down from $168.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $184.0 million in Q4 2022 to a low of -$33.3 million in Q2 2022.
  • The 5-year median for Research & Development is -$17.7 million (2023), against an average of $19.4 million.
  • Across the five-year window, Research & Development surged 61.03% in 2023 and tumbled 53.82% in 2025, its largest moves.
  • Valneva SE's Research & Development stood at $184.0 million in 2022, then sank by 40.28% to $109.9 million in 2023, then gained by 19.35% to $131.1 million in 2024, then gained by 28.75% to $168.8 million in 2025, then slumped by 110.55% to -$17.8 million in 2026.
  • The last three Research & Development figures came in at -$17.8 million (Q1 2026), $168.8 million (Q4 2025), and -$31.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 4.32 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 15.66 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 626,092.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -101.30 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 1.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -2.30 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 357,444.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 961.60 Mn
9 Abivax 94.26 Bn 94.26 Bn - -58.00 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -17.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.81 Mn
Dec 31, 2025 168.82 Mn
Sep 30, 2025 -31.90 Mn
Jun 30, 2025 -19.80 Mn
Mar 31, 2025 -15.73 Mn
Dec 31, 2024 131.13 Mn
Sep 30, 2024 -20.74 Mn
Jun 30, 2024 -17.82 Mn
Mar 31, 2024 -14.27 Mn
Dec 31, 2023 109.87 Mn
Sep 30, 2023 -17.68 Mn
Jun 30, 2023 -12.97 Mn
Mar 31, 2023 -15.10 Mn
Dec 31, 2022 183.96 Mn
Sep 30, 2022 -23.70 Mn
Jun 30, 2022 -33.29 Mn
Mar 31, 2022 -23.22 Mn
Dec 31, 2021 332.34 Mn
Sep 30, 2021 -45.40 Mn
Jun 30, 2021 -61.42 Mn